Search Within

Nancy T Sklarin

Formats
  1. Journal Article (30)
  2. Meeting Abstract (24)
Groups
  1. Breast Medicine Service (54)
  2. Department of Medicine (54)
  3. Solid Tumor Oncology Division (54)
  4. Survivorship Research (40)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (36)
  6. Behavioral Sciences Service (24)

More Groups

People
  1. Clifford Hudis (38)
  2. Larry Norton (32)
  3. Andrew Seidman (30)
  4. Teresa Gilewski (24)
  5. Monica Fornier (20)
  6. Gabriella D'Andrea-Carlino (19)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2022 (1)
  4. 2021 (1)
  5. 2019 (1)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. Breast Cancer Research and Treatment (7)
  3. Cancer Research (4)
  4. Clinical Cancer Research (4)
  5. Seminars in Oncology (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (20)
  2. American Association for Cancer Research (9)
  3. Springer (7)
  4. Elsevier Inc. (6)
  5. Lippincott Williams & Wilkins (3)
  6. Oxford University Press (3)

More Publishers

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Harmonization of the upfront osteosarcoma treatment paradigm for adolescents and young adults
    Journal Article

    Daukshus, N. P.; Avutu, V.; Long Sarro, E.; Kinnaman, M. D.; Slotkin, E. K.; Thornton, K.; Dickson, M. A.; Sklarin, N. T.; Tap, W. D.; Glade Bender, J.
    Journal of Adolescent and Young Adult Oncology (2025)

    Fulltext@MSK | Save
  • The impact of independent chemotherapy prescribing by advanced practice providers on patient safety and clinician satisfaction
    Journal Article

    LeStrange, N.; Walton, A.; Watson, J. L.; Sklarin, N. T.; Thompson, J. A.; Affronti, M. L.
    Clinical Journal of Oncology Nursing (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents
    Journal Article

    Eroglu, I.; Filippova, O. T.; Kirrane, M.; Orpen, M.; Almonte, V.; Thomas, R.; Lee-Teh, M.; Tizon, R.; Sklarin, N.; O'Cearbhaill, R.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • A phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Drago, J. Z.; Shah, P. D.; Wang, R.; Pareja, F.; Ratzon, F.; Iasonos, A.; Patil, S.; Rosen, N.; Fornier, M. N.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Feasibility of an outpatient 12-step desensitization for patients with history of carboplatin hypersensitivity reactions (HSR) undergoing retreatment with carboplatin for recurrent ovarian or endometrial cancer
    Meeting Abstract

    LaVigne, K.; Eroglu, I.; Mainardi, T.; Sabbatini, P.; Sklarin, N.; O'Cearbhaill, R.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel and dasatinib in metastatic breast cancer
    Journal Article

    Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Patient safety may be improved using a dose calculating-and-rounding electronic chemotherapy order entry and verification system with clinical decision support system (CDSS) features in the pediatric setting
    Meeting Abstract

    Gilheeney, S.; Ackerman, J.; De Luca, J.; Robinson, D.; Muller, R.; Sklarin, N.
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia
    Journal Article

    Belum, V. R.; Silva, G. D.; Laloni, M. T.; Ciccolini, K.; Goldfarb, S. B.; Norton, L.; Sklarin, N. T.; Lacouture, M. E.
    Breast Cancer Research and Treatment (2016)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save